AU2003274900A1 - Cellular reprogramming in peptide hydrogel and uses thereof - Google Patents
Cellular reprogramming in peptide hydrogel and uses thereofInfo
- Publication number
- AU2003274900A1 AU2003274900A1 AU2003274900A AU2003274900A AU2003274900A1 AU 2003274900 A1 AU2003274900 A1 AU 2003274900A1 AU 2003274900 A AU2003274900 A AU 2003274900A AU 2003274900 A AU2003274900 A AU 2003274900A AU 2003274900 A1 AU2003274900 A1 AU 2003274900A1
- Authority
- AU
- Australia
- Prior art keywords
- peptide hydrogel
- cellular reprogramming
- reprogramming
- cellular
- hydrogel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000008668 cellular reprogramming Effects 0.000 title 1
- 239000000017 hydrogel Substances 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
- C12N5/0671—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
- C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/06—Anti-neoplasic drugs, anti-retroviral drugs, e.g. azacytidine, cyclophosphamide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/14—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from hepatocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19394202A | 2002-07-15 | 2002-07-15 | |
| US10/193,942 | 2002-07-15 | ||
| PCT/US2003/021981 WO2004007683A2 (en) | 2002-07-15 | 2003-07-15 | Cellular reprogramming in peptide hydrogel and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003274900A1 true AU2003274900A1 (en) | 2004-02-02 |
| AU2003274900A8 AU2003274900A8 (en) | 2004-02-02 |
Family
ID=30114638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003274900A Abandoned AU2003274900A1 (en) | 2002-07-15 | 2003-07-15 | Cellular reprogramming in peptide hydrogel and uses thereof |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003274900A1 (en) |
| WO (1) | WO2004007683A2 (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7332336B2 (en) | 2003-08-19 | 2008-02-19 | Effector Cell Institute, Inc. | Methods for inducing differentiation of pluripotent cells |
| JP4404030B2 (en) | 2004-10-07 | 2010-01-27 | トヨタ自動車株式会社 | Control device and control method for internal combustion engine |
| US7429567B2 (en) * | 2005-01-04 | 2008-09-30 | The Brigham And Women's Hospital, Inc. | Sustained delivery of PDGF using self-assembling peptide nanofibers |
| US8299032B2 (en) | 2005-06-27 | 2012-10-30 | Menicon Co., Ltd. | Self-assembling peptide and gel produced from the same |
| JP5263756B2 (en) | 2005-09-30 | 2013-08-14 | 国立大学法人 岡山大学 | Cell culture method and cell culture |
| JP2007217375A (en) * | 2006-02-17 | 2007-08-30 | Nagoya Institute Of Technology | Self-assembling peptide |
| JP2007217376A (en) * | 2006-02-17 | 2007-08-30 | Nagoya Institute Of Technology | Self-assembling peptide composition |
| WO2008024409A1 (en) * | 2006-08-22 | 2008-02-28 | The Trustees Of Columbia University In The City Of New York | Progenitor cell replication and differentiation in 3d |
| WO2008112170A1 (en) | 2007-03-09 | 2008-09-18 | Corning Incorporated | Three dimensional gum matrices for cell culture, manufacturing methods and methods of use |
| US9084752B2 (en) * | 2009-12-14 | 2015-07-21 | The University Of Hong Kong | Compositions and methods for controlling proliferation and differentiation of cells |
| FI123988B (en) | 2010-10-27 | 2014-01-31 | Upm Kymmene Corp | Cell Culture Materials |
| US8546338B2 (en) | 2010-12-08 | 2013-10-01 | Johnson & Johnson Consumer Companies, Inc. | Self-assembling hydrogels based on dicephalic peptide amphiphiles |
| FI125965B (en) | 2012-09-25 | 2016-04-29 | Upm Kymmene Corp | Three-dimensional cell culture |
| FI126398B (en) | 2014-12-18 | 2016-11-15 | Upm Kymmene Corp | Procedure for testing chemicals |
| DE102015000363A1 (en) | 2015-01-20 | 2016-07-21 | Emc Microcollections Gmbh | New modular functionalizable peptide hydrogels |
| EP3418377B1 (en) | 2017-06-22 | 2024-04-17 | UPM-Kymmene Corporation | Supportive nanofibrillar cellulose scaffold for expanding cells |
| CN109810943A (en) * | 2019-03-21 | 2019-05-28 | 河南科技大学 | A kind of porcine muscle-derived mesenchymal stem cell separation medium and separation and culture method |
| BR112022018092A2 (en) | 2020-03-11 | 2022-11-22 | Bit Bio Ltd | METHOD OF GENERATING LIVER CELLS |
| WO2022079272A1 (en) | 2020-10-15 | 2022-04-21 | Katholieke Universiteit Leuven | Spheroidal self-assembled peptide hydrogels comprising cells |
-
2003
- 2003-07-15 WO PCT/US2003/021981 patent/WO2004007683A2/en not_active Ceased
- 2003-07-15 AU AU2003274900A patent/AU2003274900A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004007683A3 (en) | 2005-09-09 |
| AU2003274900A8 (en) | 2004-02-02 |
| WO2004007683A2 (en) | 2004-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003274900A1 (en) | Cellular reprogramming in peptide hydrogel and uses thereof | |
| AU2003238714A1 (en) | Export and modification of (poly)peptides in the lantibiotic way | |
| AU2003266143A1 (en) | Mobile location explorer and methods therefor | |
| AU2003276822A1 (en) | Lactobacilli expressing biologically active polypeptides and uses thereof | |
| AU2003300406A1 (en) | Wireless radio architectures and methods therefor | |
| AU2003290573A1 (en) | Cross-linked oligomeric compounds and their use in gene modulation | |
| AU2003280084A1 (en) | Protein arrays and uses thereof | |
| AU2003207744A1 (en) | Transport peptides and uses therefor | |
| AUPS238502A0 (en) | Cystic echinococcosis protein and uses therefor | |
| AU2003272423A1 (en) | Centrosome proteins and uses thereof | |
| AU2003290886A1 (en) | Modified alpha-msh peptides and derivatives thereof | |
| AU2003290222A1 (en) | Hypercoiling polymers and their use in cellular delivery | |
| AU2003284597A1 (en) | Apoptosis-associated protein and use thereof | |
| AU2002247088A1 (en) | Cellular reprogramming in peptide hydrogel and uses thereof | |
| AU2003280992A1 (en) | Novel proteins and use thereof | |
| AU2003292774A1 (en) | Novel proteins and use thereof | |
| AU2003213933A1 (en) | Purified polypeptides involved in protein synthesis and modification | |
| AU2003303464A1 (en) | Centrosome-associated protein and applications thereof | |
| AU2002951912A0 (en) | Tryptase polypeptide and uses thereof | |
| AU2003263751A1 (en) | Novel proteins and their uses | |
| AU2003296163A1 (en) | Cell cycle-controlling protein and utilization thereof | |
| AU2003265814A1 (en) | Aw755252-interacting proteins and use thereof | |
| AU2003202650A1 (en) | Cystic echinococcosis protein and uses therefor | |
| AU2003238562A1 (en) | Novel peptide and use thereof | |
| AU2003213936A1 (en) | Polypeptides from bacteria and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |